Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study aimed to determine the effects of mindfulness-based stress reduction training on anger management and functional recovery in patients with schizophrenia. The study will be conducted at a CMHC in Ağrı province between May and August 2021. At the CMHC, community-based mental health services are provided to patients with severe mental disorders (schizophrenia, bipolar disorder) who are in remission as assessed by a psychiatrist. The study is planned to be conducted with patients who meet the study criteria, without using a sample selection method. Patients over the age of 18 registered with CMHC and followed with a diagnosis of schizophrenia were contacted by phone and invited to CMHC. The study was conducted with patients who met the inclusion criteria and agreed to participate (psychoeducational group, mindfulness group, control group). Data will be collected using the Descriptive Characteristics Form, the State and Trait Anger Inventory, and the SILO. The mindfulness group received 16 sessions of MBRS training, and the psychoeducational group received an 8-session psychoeducational program. The control group received no intervention. The study sample size was calculated using the GPower computer program. Power analysis at α=0.05 yielded an effect size of 150, 153 (d=0.8), and the study had 90% power. Therefore, it was calculated that a minimum of 68 patients should be included in the sample.
Study data were collected by the researcher through face-to-face interviews. The study included individuals diagnosed with schizophrenia who met the inclusion criteria (registration in a CMHC, having a diagnosis of schizophrenia, willingness to participate in the study, and openness to communication and collaboration). Pre-test measurement instruments were administered to the participants. The mindfulness group then received 16 sessions of MBRS training, and the psychoeducation group received an 8-session psychoeducation program. The control group received no intervention. Post-test data were collected following the training sessions.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Session 1: Preparatory Session | Experimental | *Meeting the patients *Introducing the content of mindfulness-based stress reduction training *Emphasizing the importance of regular and timely attendance at training *Determining training dates *Sharing individuals' experiences and expectations |
|
| Session 2: Mindfulness | Experimental | *What is mindfulness? *Being aware of daily activities. *Raisin meditation. |
|
| Session 3: Our Perspectives on Ourselves and the World | Experimental | *Breathing meditation. *Habit Breaker: Watching the Sky. |
|
| Session 4: Body Scan *Body scan meditation. | Experimental | *Ten-finger gratitude practice. *Habit Breaker: Spending some time in nature. |
|
| Session 5: Recognizing Schizophrenia | Experimental | *What is schizophrenia? *What are its symptoms? *What does treatment involve? |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Session 1: Preparatory Session | Other | *Meeting the patients *Introducing the content of mindfulness-based stress reduction training *Emphasizing the importance of regular and timely attendance at training *Determining training dates *Sharing individuals' experiences and expectations |
| Measure | Description | Time Frame |
|---|---|---|
| Personal Information Form | This form consists of a total of eight questions (age, gender, marital status, education level, duration of illness, income, family history of mental illness, and employment status) developed by the researcher based on literature and includes the sociodemographic characteristics of the patients | up to 1 day |
| Measure | Description | Time Frame |
|---|---|---|
| The State-Trait Anger Scale (STAS) | This is a self-report scale measuring the feeling and expression of anger. It was developed by Spielberger et al., and its Turkish validity and reliability study was conducted by Özer. The Cronbach's alpha obtained in this study was 0.84. The scale is a four-point Likert-type scale consisting of four subscales: anger-in, anger-out, anger control, and trait anger, and 34 items. High scores on the trait anger dimension indicate high anger levels, high scores on the anger control dimension indicate that anger can be controlled, high scores on the anger-out dimension indicate that anger is easily expressed, and high scores on the anger-in dimension indicate that anger is suppressed. |
| Measure | Description | Time Frame |
|---|---|---|
| Functional Recovery Scale in Schizophrenia (FRS) | The Functional Recovery Scale in Schizophrenia (FRS) was developed by Llorca et al. in 2009. The scale's validity and reliability in Turkey were conducted by EmiroÄŸlu in 2009. The validity and reliability coefficient of the scale was determined to be 0.94. In this study, the Chronbach's alpha coefficient was determined to be 0.91. It is a 5-point Likert-type scale consisting of 19 items and 4 subscales. As the scores on the scale increase, the level of functional recovery increases. Dimensions: Social Functioning (7 items), Health and Treatment (4 items), Daily Living Skills (6 items), Occupational Functioning (2 items). The lowest score that can be obtained from the scale is 19, the highest score is 95. |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Mine Cengiz lecturer doctor | Ataturk University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Ataturk University Faculty of Nursing | Erzurum | Yakutiye | Turkey (Türkiye) |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Session 6: Mindful Movement | Experimental | *Mindfulness movement meditation practice * |
|
| Session 7: Mindful Breathing | Experimental | *Breathing meditation |
|
| Session 8: Treatment Evaluation | Experimental | *The importance of medication *Things to consider when using medication *Side effects of medication *What is a flare-up in schizophrenia? *What are the precursor symptoms? |
|
| Session 9: Mindful Thinking | Experimental | *Sounds and thoughts meditation *Cinema activity. |
|
| Session 10: Coping with Anger | Experimental | *What is anger? *What are its symptoms? *What are the coping methods? |
|
| Session 11: Coping with Difficult Emotions | Experimental | *Facing Difficulties meditation |
|
| Session 12: Mindful Communication | Experimental | *Communication & mindful communication *The importance of communication skills *Fundamentals of communication, self-language practice *Ways to prevent communication accidents |
|
| Session 13: Different Connections | Experimental | *Breathing meditation. *Habit Breaker: Thought and Emotional Play. |
|
| Session 14: The Joy of the Small Things | Experimental | *Treasure Treasure Meditation *Habit Breaker: Letter to Self. |
|
| Session 15: Dwelling on the Past or Living in the Present? | Experimental | *Friendship-Building Meditation *Habit Breaker: Random Acts of Kindness. |
|
| Session 16: Evaluation *Reinforcing What Has Been Learned. | Experimental | *Evaluating the Program. *Obtaining Feedback. |
|
| Group 2: 2: Recognizing the Illness | Active Comparator | *What is schizophrenia? *What are its symptoms? *What does treatment involve? |
|
| Group 2: Session 3: Evaluating Treatment | Active Comparator | *Considerations regarding medication use *Side effects of medication use *Exacerbations in schizophrenia *Premonitory symptoms. |
|
| Group 2: Session 4: *What is anger? | Active Comparator | *What are the symptoms of anger? *What are the methods for coping with anger? |
|
| Group 2: Session 5: Communication *What is communication? | Active Comparator | *The importance of communication. *Fundamentals of communication, self-language practice *Ways to prevent communication difficulties. |
|
| Group 2: Session 6: What is relaxation? | Active Comparator | What is progressive relaxation. Relaxation CD introduction |
|
| Group 2: Session 7: Relaxation | Active Comparator | Performing the relaxation CD with patients |
|
| Group 2: Session 8: Evaluation | Active Comparator | *Reinforcement of what has been learned. *Evaluation of the program. *Receiving feedback |
|
| Group 2: Session 1: Preparatory Session | Active Comparator | *Meeting the patients *Introducing the content of psychoeducation *Emphasizing the importance of regular and timely attendance at training *Determining training dates *Sharing individuals' experiences and expectations |
|
|
| Session 2: Mindfulness | Other | *What is mindfulness? *Being aware of daily activities. *Raisin meditation. |
|
| Session 3: Our Perspectives on Ourselves and the World | Other | *Breathing meditation. *Habit Breaker: Watching the Sky. |
|
| Session 4: Body Scan *Body scan meditation. | Other | *Ten-finger gratitude practice. *Habit Breaker: Spending some time in nature. |
|
| Session 5: Recognizing Schizophrenia | Other | *What is schizophrenia? *What are its symptoms? *What does treatment involve? |
|
| Session 6: Mindful Movement | Other | *Mindfulness movement meditation practice * |
|
| Session 7: Mindful Breathing | Other | *Breathing meditation * |
|
| Session 8: Treatment Evaluation | Other | *The importance of medication *Things to consider when using medication *Side effects of medication *What is a flare-up in schizophrenia? *What are the precursor symptoms? |
|
| Session 9: Mindful Thinking | Other | *Sounds and thoughts meditation *Cinema activity. |
|
| Session 10: Coping with Anger | Other | *What is anger? *What are its symptoms? *What are the coping methods? |
|
| Session 11: Coping with Difficult Emotions | Other | *Facing Difficulties meditation * |
|
| Session 12: Mindful Communication | Other | *Communication & mindful communication *The importance of communication skills *Fundamentals of communication, self-language practice *Ways to prevent communication accidents |
|
| Session 13: Different Connections | Other | *Breathing meditation. *Habit Breaker: Thought and Emotional Play. |
|
| Session 14: The Joy of Small Things | Other | *Treasure of Pleasure Meditation *Habit Breaker: Letter to Self. |
|
| Session 15: Dwelling on the Past or Living in the Present? | Other | *Friendship-Building Meditation *Habit Breaker: Random Acts of Kindness. |
|
| Session 16: Evaluation | Other | *Reinforcing What Has Been Learned. *Evaluating the Program. *Obtaining Feedback. |
|
| Session 1: Group 2, Preparation Session | Other | *Meeting Patients *Introducing the Content of Psychoeducation *Emphasizing the Importance of Regular and Timely Attendance at Training *Determining Training Dates *Sharing Individuals' Experiences and Expectations |
|
|
| Session 2: Group 2, Recognizing the Illness | Other | *What is Schizophrenia? *What are its Symptoms? *What Does Treatment Include? |
|
| Session 3: Group 2, Treatment Evaluation | Other | *Things to Consider When Using Medication *Side Effects of Medication *Exacerbation of Schizophrenia *Precursor Symptoms. |
|
| Session 4: Group 2, What is anger? | Other | *What are the symptoms of anger? *What are the methods for coping with anger? |
|
| Session 5: Group 2, Communication | Other | *What is communication? *The importance of communication. *Fundamentals of communication, working on "I" language. *Ways to prevent communication difficulties. |
|
| Session 6: Group 2, What is relaxation? | Other | What is progressive relaxation? Introducing a relaxation CD |
|
| Session 7: Group 2, Relaxation | Other | Practicing the relaxation CD with patients |
|
| Session 8: Group 2, Evaluation | Other | *Reinforcing what has been learned. *Evaluating the program. *Obtaining feedback |
|
| up to 1 day |
| up to 1 day |
| ID | Term |
|---|---|
| D012559 | Schizophrenia |
| ID | Term |
|---|---|
| D019967 | Schizophrenia Spectrum and Other Psychotic Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided
| ID | Term |
|---|---|
| C110804 | mycophenolic adenine dinucleotide |
Not provided
Not provided
Not provided